Brands: Octreotide · Sandostatin · Octreotide Acetate
Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi, USA LLC | generic | 6 | SUPPLYING |
| Sagent Pharmaceuticals | generic | 5 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | generic | 5 | SUPPLYING |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | generic | 5 | SUPPLYING |
| Gland Pharma Limited | generic | 4 | SUPPLYING |
| Mylan Institutional LLC | unknown | 3 | SUPPLYING |
| Novartis Pharmaceuticals Corporation | unknown | 3 | SUPPLYING |
| Meitheal Pharmaceuticals Inc. | generic | 3 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | generic | 2 | SUPPLYING |
| Hainan Shuangcheng Pharmaceuticals Co., Ltd. | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe. — Recalling firm: Viatris Inc — Nationwide in the USA
